| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/03/2004 | US20040105887 Controlled release oxycodone compositions |
| 06/03/2004 | US20040105886 valproic acid moiety of the divalproex sodium is neutralized by addition of a strong base formulated into stable solid oral dosage forms even in the absence of oligomeric structure and equimolar ratio of sodium valproate and valproic acid |
| 06/03/2004 | US20040105885 Gelatin capsule exhibiting reduced cross-linking |
| 06/03/2004 | US20040105884 sulfites, such as: sodium metabisulfite, sodium bisulfite, and sodium thiosulfate allow capsule to consistently meet desired in vitro dissolution criteria, even after storage under stressed conditions |
| 06/03/2004 | US20040105883 Amines, such as: ethanolamine, ethylenediamine, diethylamine allow capsule to consistently meet desired in vitro dissolution criteria, even after storage under stressed conditions |
| 06/03/2004 | US20040105881 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 06/03/2004 | US20040105876 comprising dissipatable blocking agent, which after dissipation, leaves the cross-linking agent free to cross-link the functional groups of the film-forming polymer |
| 06/03/2004 | US20040105875 effective in smoothing out or eliminating expression wrinkles and fine lines; having the property of increasing collagen synthesis by the fibroblasts and of moisturizing the skin |
| 06/03/2004 | US20040105872 which contains a cytosine, guanine dinucleotide sequence and stimulates (for example, has a mitogenic effect) vertebrate immune cells |
| 06/03/2004 | US20040105870 comprised of lecithin, antioxidants and vitamin B complex; a deficiency in choline may result in the inability of the liver to transport fatty acids such as triglycerides |
| 06/03/2004 | US20040105864 Food supplement |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |
| 06/03/2004 | US20040105852 Parenteral composition for treating bacterial illnesses |
| 06/03/2004 | US20040105850 Administering nitrosated angiotensin converting enzyme inhibitors and other nitrosated compounds for cardiovascular disorders and treatment of hypertensive agents |
| 06/03/2004 | US20040105849 spinal muscular atrophy diseases for genetic disorders treatment with vitamin c and pectins, flavonoids, enzyme supplements or enteric bacterium |
| 06/03/2004 | US20040105848 Enteric dialysis to treat renal, kidney and gastrointestinal problems andprobiotic bacteria to reduce urea |
| 06/03/2004 | US20040105842 treating an individual having Alzheimer's Disease or at risk for Alzheimer's Disease or other inflammatory/degenerative neurological diseases, comprising the administering an anti-cholinesterase agent and alpha interferon |
| 06/03/2004 | US20040105838 Orlistat compositions |
| 06/03/2004 | US20040105822 Combinations of formoterol and mometasone furoate for asthma |
| 06/03/2004 | US20040105821 Sustained release pharmaceutical formulation for inhalation |
| 06/03/2004 | US20040105819 Respiratory drug condensation aerosols and methods of making and using them |
| 06/03/2004 | US20040105818 Diuretic aerosols and methods of making and using them |
| 06/03/2004 | US20040105798 Sterilizing tunnel for pharmaceutical containers |
| 06/03/2004 | US20040104142 Blister package for topiramate tablets |
| 06/03/2004 | US20040103902 Condom with an erectogenic composition |
| 06/03/2004 | DE3744542B4 Pharmazeutische Verwendung von L-δ-Hydroxylysin Pharmaceutical use of L-δ-hydroxylysine |
| 06/03/2004 | DE19929995B4 Verwendung von Kreatin und/oder Kreatin-Derivaten zur Behandlung von Befindlichkeitsstörungen bei Frauen Use of creatine and / or creatine derivatives for the treatment of mood disorders in women |
| 06/03/2004 | DE10255236A1 Purification of racemic or non-racemic lipoic acid, comprising using adsorbent such as silica gel to remove oligomeric impurities |
| 06/03/2004 | DE10254872A1 Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe Anthranilic acid and derivatives thereof as cosmetic and pharmaceutical ingredients |
| 06/03/2004 | DE10254822A1 Treating Parkinson's disease using nefazodone optionally together with trazodone and/or cetirizine, for reducing dopamine requirement and alleviating symptoms |
| 06/03/2004 | DE10254785A1 Synergistic mixture of analgesic and inhibitor of cyclo-oxygenase II, useful for treatment of pain, effective at low doses and with reduced side effects |
| 06/03/2004 | DE10251809A1 Medicinal drink used e.g. for treating pain or fever or preventing vascular occlusion or cancer comprises water containing dissolved acetylsalicylic acid |
| 06/03/2004 | DE10133305B4 Ubichinon Konzentrat Ubiquinone concentrate |
| 06/03/2004 | CA2546696A1 Polymeric boronic acid derivatives as lipase inhibitors |
| 06/03/2004 | CA2543393A1 Combination of monounsaturated fatty acids and estrogen, and their use |
| 06/03/2004 | CA2506850A1 Compounds and methods for increasing neurogenesis |
| 06/03/2004 | CA2506842A1 Amplification of biotin-mediated targeting |
| 06/03/2004 | CA2506704A1 Peritoneal dialysis method |
| 06/03/2004 | CA2506673A1 Treatment of gastrointestinal disorders with duloxetine |
| 06/03/2004 | CA2506615A1 Analgesic uses of norketamine and ketamine/norketamine prodrugs |
| 06/03/2004 | CA2506576A1 Amino-lna, thio-lna and alpha-l-oxy-ln |
| 06/03/2004 | CA2506504A1 Treatment of lung cells with histone deacetylase inhibitors |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2506397A1 Method and apparatus for the detection and occlusion of blood vessels |
| 06/03/2004 | CA2506340A1 Novel lapachone compounds and methods of use thereof |
| 06/03/2004 | CA2506316A1 Substituted indolepyridinium as anti-infective compounds |
| 06/03/2004 | CA2506308A1 Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 06/03/2004 | CA2506245A1 Exon 1.beta. of pdgf receptor .alpha. gene and utilization thereof |
| 06/03/2004 | CA2506236A1 Compositions and uses of dalbavancin for treatment of bacterial infections |
| 06/03/2004 | CA2506232A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 06/03/2004 | CA2506231A1 Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
| 06/03/2004 | CA2506230A1 Anti-angiogenic uses of il-6 antagonists |
| 06/03/2004 | CA2506129A1 2'-branched nucleosides and flaviviridae mutation |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/03/2004 | CA2506109A1 Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments |
| 06/03/2004 | CA2506085A1 Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer |
| 06/03/2004 | CA2506084A1 Inositolized phospholipids |
| 06/03/2004 | CA2506083A1 Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonane compounds and method of treatments relating to arrhythminc events |
| 06/03/2004 | CA2505915A1 Method of lowering crp and reducing systemic inflammation |
| 06/03/2004 | CA2505809A1 Compositions and method for treating affective, painful or allergic disorders |
| 06/03/2004 | CA2505789A1 Diaminotriazoles useful as inhibitors of protein kinases |
| 06/03/2004 | CA2505486A1 Process to minimize loss through adhesion to equipment surfaces |
| 06/03/2004 | CA2505485A1 Pharmaceutical tablets containing tibolone and a coating |
| 06/03/2004 | CA2505377A1 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | CA2504250A1 Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | CA2502700A1 Diagnostic method for celiac sprue |
| 06/03/2004 | CA2502025A1 Pharmaceutical compositions having a modified vehicle |
| 06/03/2004 | CA2472815A1 Improved process for preparation of gabapentin |
| 06/02/2004 | EP1424399A1 Process for the enzymatic reduction of NAD and NADP |
| 06/02/2004 | EP1424336A1 1,3-benzothiazinone derivatives and use thereof |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424333A1 Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
| 06/02/2004 | EP1424329A1 Method of preparing 4-(imidazole-1-il)benzenesulphonamide derivatives |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1424101A2 Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis |
| 06/02/2004 | EP1424081A1 Polysaccharide-containing compositions and use thereof |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1424079A1 Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| 06/02/2004 | EP1424078A1 Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller |
| 06/02/2004 | EP1424076A1 Use of green coffee extract as mineral absorption enhancer |
| 06/02/2004 | EP1424074A1 Nutritional compositions for controlling blood glucose level |
| 06/02/2004 | EP1424073A1 Anti diarrhoea compositions |
| 06/02/2004 | EP1424071A1 Perfume compositions |
| 06/02/2004 | EP1424070A1 Combination of a PPAR alpha agonist and metformin for decreasing the serum triglycerides |
| 06/02/2004 | EP1424068A1 Process for the preparation of pellets comprising a tricyclic or tetracyclic antidepressant and pharmaceutical compositions comprising these pellets |
| 06/02/2004 | EP1424067A1 Injectable foam and novel pharmaceutical applications thereof |
| 06/02/2004 | EP1424062A1 Screening composition containing at least one dibenzoylmethane derivative and at least one 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one; photostabilisation process |
| 06/02/2004 | EP1423693A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy |
| 06/02/2004 | EP1423436A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423407A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423404A2 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/02/2004 | EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 06/02/2004 | EP1423392A1 Derivatives of morphine-like opioid compounds |
| 06/02/2004 | EP1423391A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |